Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

Small vessel vasculitis is the most common cause of vasculitis in patients with LE and may be secondary to other rheumatic diseases such as rheumatoid arthritis, dermatomyositis, and Sjogren's ...

VEXAS syndrome is known to be a mimicker of ANCA-associated vasculitis, making it a challenge to distinguish between the disorders. VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic ...

Researchers from The University of Osaka discover new biomarkers at the cell and protein levels for predicting relapse of ...

More information: Masayuki Nishide et al, Neutrophil single-cell analysis identifies a type II interferon-related subset for predicting relapse of autoimmune small vessel vasculitis, Nature ...

In the study, the time of AAV diagnosis was defined as “the date of a biopsy confirming small vessel vasculitis or, if no biopsy was performed, the initiation of immunosuppressive therapy.” ...

Each underwent an extensive workup including 4-vessel cerebral ... We report a small case series of patients empirically treated for suspected CNS vasculitis, who were found to have other diseases ...

It typically begins with a fever and vasculitis, a type of blood vessel inflammation, and may involve gastrointestinal and other symptoms. If left untreated, Kawasaki disease can lead to coronary ...